Montana § 37-27-312 Screening Procedures

Montana Statutes

§ 37-27-312 — Screening Procedures

Montana § 37-27-312

Title 37PROFESSIONS AND OCCUPATIONS

Ch. 27DIRECT-ENTRY MIDWIFERY

Part 3Regulation of Practice

This text of Montana § 37-27-312 (Screening Procedures) is published on Counsel Stack Legal Research, covering Montana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Mont. Code Ann. § 37-27-312 (2026).

Text

37-27-312 . Screening procedures. In addition to meeting the eligibility criteria for client screening established by the board pursuant to 37-27-105 , a direct-entry midwife shall recommend that patients secure the following services by an appropriate health care provider:

(1)the standard serological test, as defined in 50-19-101 , for women seeking prenatal care;

(2)screening for human immunodeficiency virus, when appropriate;

(3)maternal serum alpha-fetoprotein test and ultrasound, upon request;

(4)Rh antibody and glucose screening at 28 weeks' gestation, upon request;

(5)nonstress testing by a fetal monitor of a fetus at greater than 42 1/2 weeks' gestation or if other reasons indicate the testing;

(6)screening for phenylketonuria;

(7)Rh screening of the infant for RhoGAM treatm

Free access — add to your briefcase to read the full text and ask questions with AI

37-27-312 . Screening procedures. In addition to meeting the eligibility criteria for client screening established by the board pursuant to 37-27-105 , a direct-entry midwife shall recommend that patients secure the following services by an appropriate health care provider:
(1) the standard serological test, as defined in 50-19-101 , for women seeking prenatal care;
(2) screening for human immunodeficiency virus, when appropriate;
(3) maternal serum alpha-fetoprotein test and ultrasound, upon request;
(4) Rh antibody and glucose screening at 28 weeks' gestation, upon request;
(5) nonstress testing by a fetal monitor of a fetus at greater than 42 1/2 weeks' gestation or if other reasons indicate the testing;
(6) screening for phenylketonuria;
(7) Rh screening of the infant for RhoGAM treatment if the mother is Rh negative; and
(8) screening for premature labor and other risk factors.